124 related articles for article (PubMed ID: 1282853)
21. Peptide-mediated allo-recognition of HLA-B27 by cytotoxic T lymphocytes.
Rojo S; López de Castro JA
Int J Cancer Suppl; 1991; 6():10-3. PubMed ID: 1712346
[TBL] [Abstract][Full Text] [Related]
22. High T cell epitope sharing between two HLA-B27 subtypes (B*2705 and B*2709) differentially associated to ankylosing spondylitis.
García-Peydró M; Martí M; López de Castro JA
J Immunol; 1999 Aug; 163(4):2299-305. PubMed ID: 10438975
[TBL] [Abstract][Full Text] [Related]
23. Peptide-presenting similarities among functionally distant HLA-B27 subtypes revealed by alloreactive T lymphocytes of unusual specificity.
López D; Rojo S; Calvo V; López de Castro JA
J Immunol; 1992 Feb; 148(4):996-1002. PubMed ID: 1371137
[TBL] [Abstract][Full Text] [Related]
24. Allele-specific B pocket transplant in class I major histocompatibility complex protein changes requirement for anchor residue at P2 of peptide.
Colbert RA; Rowland-Jones SL; McMichael AJ; Frelinger JA
Proc Natl Acad Sci U S A; 1993 Jul; 90(14):6879-83. PubMed ID: 7688130
[TBL] [Abstract][Full Text] [Related]
25. In vitro mutagenesis of HLA-B27. Substitution of an unpaired cysteine residue in the alpha 1 domain causes loss of antibody-defined epitopes.
Taurog JD; el-Zaatari FA
J Clin Invest; 1988 Sep; 82(3):987-92. PubMed ID: 2458390
[TBL] [Abstract][Full Text] [Related]
26. Fine specificity of HLA-B27 cellular allorecognition. HLA-B27f is a functional variant distinguishable by cytolytic T cell clones.
Aparicio P; Rojo S; Jaraquemada D; López de Castro JA
J Immunol; 1987 Aug; 139(3):837-41. PubMed ID: 2439595
[TBL] [Abstract][Full Text] [Related]
27. Structure and immune recognition of HLA-B27 antigens: implications for disease association.
López de Castro JA; Bragado R; Lauzurica P; López D; Rojo S
Scand J Rheumatol Suppl; 1990; 87():21-31. PubMed ID: 1701918
[TBL] [Abstract][Full Text] [Related]
28. Delineation of determinants on HLA-B7 and HLA-B27 that are necessary for cytolytic T cell recognition by using inter- and intra-domain recombinants.
Healy F; Toubert A; Gomard E; Jordan BR; Levy JP
J Immunol; 1989 Oct; 143(7):2357-63. PubMed ID: 2476507
[TBL] [Abstract][Full Text] [Related]
29. A patient-derived cytotoxic T-lymphocyte clone and two peptide-dependent monoclonal antibodies recognize HLA-B27-peptide complexes with low stringency for peptide sequences.
Huang F; Hermann E; Wang J; Cheng XK; Tsai WC; Wen J; Kuipers JG; Kellner H; Ackermann B; Roth G; Williams KM; Yu DK; Raybourne RB
Infect Immun; 1996 Jan; 64(1):120-7. PubMed ID: 8557329
[TBL] [Abstract][Full Text] [Related]
30. A new variant cytotoxic T lymphocyte escape mutation in HLA-B27-positive individuals infected with HIV type 1.
Ammaranond P; Zaunders J; Satchell C; van Bockel D; Cooper DA; Kelleher AD
AIDS Res Hum Retroviruses; 2005 May; 21(5):395-7. PubMed ID: 15929701
[TBL] [Abstract][Full Text] [Related]
31. Clonal heterogeneity of HLA-B27 cellular allorecognition. Delineation of immunodominant sites.
Aparicio P; Jaraquemada D; Rojo S; López de Castro JA
Eur J Immunol; 1988 Feb; 18(2):203-9. PubMed ID: 2450755
[TBL] [Abstract][Full Text] [Related]
32. Importance of a conserved TCR J alpha-encoded tyrosine for T cell recognition of an HLA B27/peptide complex.
Bowness P; Allen RL; Barclay DN; Jones EY; McMichael AJ
Eur J Immunol; 1998 Sep; 28(9):2704-13. PubMed ID: 9754558
[TBL] [Abstract][Full Text] [Related]
33. Cross-reactivity among evolutionarily distant major histocompatibility complex class I molecules (HLA-B27 and H-2Kk) revealed by xenoreactive T lymphocytes.
Frangoulis B; Reboul M; Rocca A; Pla M
Eur J Immunol; 1993 Feb; 23(2):338-42. PubMed ID: 8436169
[TBL] [Abstract][Full Text] [Related]
34. Strong memory CD8+ T cell responses against immunodominant and three new subdominant HLA-B27-restricted influenza A CTL epitopes following secondary infection of HLA-B27 transgenic mice.
Cheuk E; Chamberlain JW
Cell Immunol; 2005 Apr; 234(2):110-23. PubMed ID: 16054612
[TBL] [Abstract][Full Text] [Related]
35. Cytotoxic T lymphocyte-defined epitope differences between HLA-A2.1 and HLA-A2.2 map to two distinct regions of the molecule.
Hogan KT; Clayberger C; Le AX; Walk SF; Ridge JP; Parham P; Krensky AM; Engelhard VH
J Immunol; 1988 Dec; 141(11):4005-11. PubMed ID: 2460555
[TBL] [Abstract][Full Text] [Related]
36. The solvent-inaccessible Cys67 residue of HLA-B27 contributes to T cell recognition of HLA-B27/peptide complexes.
Appel H; Kuon W; Kuhne M; Hülsmeyer M; Kollnberger S; Kuhlmann S; Weiss E; Zeitz M; Wucherpfennig K; Bowness P; Sieper J
J Immunol; 2004 Dec; 173(11):6564-73. PubMed ID: 15557146
[TBL] [Abstract][Full Text] [Related]
37. Identification of T cell receptor recognition residues for a viral peptide presented by HLA B27.
Bowness P; Allen RL; McMichael AJ
Eur J Immunol; 1994 Oct; 24(10):2357-63. PubMed ID: 7523137
[TBL] [Abstract][Full Text] [Related]
38. TCRB junctional regions from HLA-B27-restricted T cells and HLA-B27 binding peptides display conserved hydropathy profiles in the absence of primary sequence homology.
May E; Duchmann R; Ackermann B; Meyer zum Büschenfelde KH; Märker-Hermann E
Int Immunol; 1996 Nov; 8(11):1815-23. PubMed ID: 8943577
[TBL] [Abstract][Full Text] [Related]
39. Analysis of HLA B27 in ankylosing spondylitis with human alloreactive cytolytic T lymphocyte clones: failure to detect disease-related T cell epitopes.
Czitrom AA; Pototschnik R; Edwards S; Gladman DD; Falk JA
Exp Clin Immunogenet; 1986; 3(3):129-37. PubMed ID: 2484102
[TBL] [Abstract][Full Text] [Related]
40. Residues in pockets B and F of HLA-B27 are critical in the presentation of an influenza A virus nucleoprotein peptide and influence the stability of peptide - MHC complexes.
Carreno BM; Winter CC; Taurog JD; Hansen TH; Biddison WE
Int Immunol; 1993 Apr; 5(4):353-60. PubMed ID: 8494822
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
